Related Experiment Videos
Is prevention of ischemic heart disease possible in hypertensives?
1Department of Medicine, Ostra Hospital, Göteborg, Sweden.
Insights
High blood pressure elevates risks for heart attack and arrhythmias. Antihypertensive treatments must not worsen atherosclerosis, with ongoing research into optimal drug choices for preventing ischemic heart disease.
Area of Science:
- Cardiology
- Hypertension Research
- Pharmacology
Background:
- High blood pressure (BP) is linked to myocardial hypertrophy and coronary arteriosclerosis.
- Combined cardiac and vascular effects increase risks of myocardial infarction and arrhythmias.
- Smoking and lipid disturbances also elevate ischemic heart disease (IHD) risk, even with moderate BP elevation.
Purpose of the Study:
- To evaluate the impact of antihypertensive treatments on atherosclerosis.
- To determine the efficacy of different drugs in preventing IHD events.
- To assess the safety and benefits of specific antihypertensive agents.
Main Methods:
- Review of existing clinical trials on antihypertensive treatments.
- Analysis of drug effects on myocardial and coronary processes.
- Investigation into the role of hormones and electrolytes in cardiovascular events.
Main Results:
- Antihypertensive treatment trials have been underpowered and short-term, yielding inconclusive results on IHD prevention.
- Beta-blocking drugs show potential for IHD prevention in hypertensive patients and post-myocardial infarction.
- Diuretics may pose risks due to electrolyte disturbances, potentially increasing arrhythmia risk.
Conclusions:
- Careful selection of antihypertensive medications is crucial to avoid exacerbating atherosclerosis.
- Beta-blockers may offer dual benefits for hypertension and IHD prevention.
- Further research is needed to establish definitive evidence for specific antihypertensive drug classes in IHD prevention.
Abstract:
High blood pressure (BP) leads to myocardial hypertrophy, a process in which catecholamines, and probably other hormones, are involved. The increased BP also enhances coronary arteriosclerosis, and the combination of myocardial and coronary effects increases the risk of myocardial infarction and arrhythmias. The risk of ischemic heart disease (IHD) is also influenced by smoking and lipid disturbances, and the risk of IHD events increases already at moderate BP elevation. It is important that the antihypertensive treatment does not adversely affect the arteriosclerotic process, which is a major threat for hypertensive patients. Trials of anti-hypertensive treatment have all been of low power and relatively short duration and therefore have not provided a definite answer concerning a significant effect on IHD. Investigations are being performed to determine whether certain drugs are more advantageous than others in preventing IHD events. In addition to their hypotensive effects in hypertensive patients, beta-blocking drugs may prevent IHD in accordance with their preventive effects in patients who have suffered a myocardial infarction. Diuretics may, however, be hazardous because of their effects on electrolytes-notably potassium-thereby increasing the risk of arrhythmias.